ADAPT I Ltd. 4
4 · Caris Life Sciences, Inc. · Filed Jun 23, 2025
Insider Transaction Report
Form 4
ADAPT I Ltd.
10% Owner
Transactions
- Conversion
Series A Preferred Stock
2025-06-20−14,000,000→ 0 total(indirect: See Footnotes)Exercise: $0.00→ Common Stock (3,500,003 underlying) - Conversion
Common Stock
2025-06-20+3,500,003→ 16,943,232 total(indirect: See Footnotes)
Footnotes (3)
- [F1]Each share of preferred stock automatically converted into 0.25 shares of Common Stock of the Issuer upon the closing of the initial public offering of the Issuer's Common Stock.
- [F2]The Common Stock reported herein includes 8,528,805 shares of Common Stock held of record by ADAPT I Ltd. and 8,414,427 shares of Common Stock held of record by Carisome I, L.P. Two family trusts are separately the general partner of ADAPT I Ltd. and the managing general partner of Carisome I, L.P., respectively. David D. Halbert is the trustee of each of the two family trusts, and in such capacities, has voting and investment power with respect to the shares held of record by each of the foregoing entities. Mr. Halbert disclaims beneficial ownership except to the extent of his pecuniary interest therein.
- [F3]The preferred stock reported herein includes 3,500,003 shares of Common Stock underlying Series A Preferred Stock held of record by ADAPT I Ltd..